Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1657
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18023130 | METHOD FOR REMOVING ANTIFOAMING AGENTS FROM A FERMENTATION BROTH | Final Rejection | BASF SE |
| 18256542 | UPCYCLING MIXED WASTE PLASTIC THROUGH CHEMICAL DEPOLYMERIZATION AND BIOLOGICAL FUNNELING | Non-Final OA | Alliance for Sustainable Energy, LLC |
| 18125616 | IMPROVED PROCESS FOR THE SEPARATION AND ANALYSIS OF PANCREATIC ENZYMES | Final Rejection | Kashiv BioSciences, LLC |
| 18244685 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING EYE DISORDERS | Non-Final OA | MarvelBiome, Inc. |
| 18838967 | PHOTOSYNTHETICALLY CONTROLLED SPIRULINA PRODUCTS WITH ENHANCED CONTENT AND/OR BIOAVAILABILITY OF UNOPPOSED, ACTIVE VITAMIN B12 | Final Rejection | Vaxa Technologeis Ltd. |
| 18008364 | NOVEL FAECALIBACTERIUM PRAUSNITZII STRAIN EB-FPDK9 AND USE THEREOF | Non-Final OA | ENTEROBIOME INC. |
| 18012112 | COMPOSITION FOR PROMOTING PRODUCTION OF INTERLEUKIN-10 | Non-Final OA | MEIJI CO., LTD. |
| 17915903 | CARBOHYDRATE BINDING MODULE VARIANTS | Final Rejection | Novozymes A/S |
| 17434967 | FERMENTATIVE PRODUCTION OF CARBOHYDRATES BY MICROBIAL CELLS UTILIZING A MIXED FEEDSTOCK | Non-Final OA | Chr Hansen A/S |
| 17596422 | ANTIBODY PURIFICATION METHODS AND COMPOSITIONS THEREOF | Final Rejection | Takeda Pharmaceutical Company LImited |
| 17289377 | METHOD TO USE INDUSTRIAL CO2 CONTAINING GAS FOR THE PRODUCTION OF A METHANE ENRICHED GAS COMPOSITION | Non-Final OA | ELECTROCHAEA GMBH |
| 17436893 | SELECTION MEDIUM FOR BACTERIA BELONGING TO GENUS PSEUDOMONAS AND USE THEREOF | Final Rejection | KABUSHIKI KAISHA YAKULT HONSHA |
| 17436892 | CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION | Final Rejection | Obsidian Therapeutics, Inc. |
| 17820921 | NON-CALORIC SWEETENERS AND METHODS FOR SYNTHESIZING | Final Rejection | Conagen Inc. |
| 17611312 | COMPOSITION | Non-Final OA | MORINAGA MILK INDUSTRY CO., LTD. |
| 17772464 | RECOMBINANT ACE2-FC FUSION MOLECULES AND METHODS OF MAKING AND USING THEREOF | Non-Final OA | BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD. |
| 18003018 | METHOD FOR PREPARING RECOMBINANT HUMAN EXTRACELLULAR MATRIX STRUCTURAL PROTEIN | Final Rejection | GuangZhou JiDa Biological Technology Co., Ltd |
| 17278410 | PESTICIDAL COMBINATIONS OF YERSINIA AND BACILLUS | Final Rejection | NOVOZYMES BIOAG A/S |
| 17775253 | DEOXYRIBONUCLEASE VARIANTS AND USES THEREOF | Non-Final OA | THERMO FISHER SCIENTIFIC BALTICS UAB |
| 17638166 | Tryptase Activity Measurement Substrate | Non-Final OA | Peptide Support Co. Ltd. |
| 17559978 | METHODS OF PURIFYING CHARGE-SHIELDED FUSION PROTEINS | Non-Final OA | Pfenex, Inc. |
| 17405927 | HOST YEAST CELLS AND METHODS USEFUL FOR PRODUCING INDIGOIDINE | Final Rejection | NATIONAL TECHNOLOGY AND ENGINEERING SOLUTIONS OF SANDIA, LLC |
| 17616968 | LACTOBACILLUS COMPOSITIONS AND USES THEREOF | Non-Final OA | Probi AB |
| 17383109 | METHODS OF PRODUCING AND USING RECOMBINANT ALPHA 1-ANTITRYPSIN (AAT) AND COMPOSITIONS THEREOF | Final Rejection | EXCELLGENE SA |
| 17416822 | METHOD FOR DETECTING AND ENUMERATING OF LOW CONCENTRATIONS OF LISTERIA | Final Rejection | SENSILIST AS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy